天津医药

天津医药 ›› 2020, Vol. 48 ›› Issue (6): 542-546.

• 临床研究 • 上一篇    下一篇

局部晚期喉癌手术与非手术综合治疗的远期疗效分析

杨蓉，叶贝贝，闫云飞，张文超△
  

  1. 天津医科大学肿瘤医院颌面耳鼻喉肿瘤科，国家肿瘤临床医学研究中心，天津市“肿瘤防治”重点实验室，天津市恶性肿瘤临床
    医学研究中心（邮编    300060）

  • 收稿日期:2019-10-14 修回日期:2020-03-23 出版日期:2020-06-15 发布日期:2020-06-15
  • 通讯作者: 张文超 E-mail:zwbeyond_999@sina.com
  • 基金资助:
    天津市卫生局科技基金资助项目

Analysis of the long-term efficacy between surgical and non-surgical comprehensive therapies for locally advanced laryngeal cancer

YANG Rong, YE Bei-bei, YAN Yun-fei, ZHANG Wen-chao△ #br#   

  1. Department of Maxillofacial and Otorhinolaryngology Oncology, Tianjin Medical University Cancer & Hospital, National
    Clinical Research Center for Cancer, Tianjin Key Laboratory of Cancer Prevention and Therapy, Tianjin    ’s
    Clinical Research Center for Cancer, Tianjin 300060, China
  • Received:2019-10-14 Revised:2020-03-23 Published:2020-06-15 Online:2020-06-15
  • Contact: ZHANG WEN CHAO E-mail:zwbeyond_999@sina.com

PDF (PC)

2320

PDF (Mobile)

11

摘要： 摘要：目的 比较手术与非手术综合治疗对于局部晚期喉癌（T3~4N0~3M0）的远期疗效，探讨晚期喉癌治疗方式的 选择。方法 回顾分析我院初诊的190例局部晚期喉癌患者经手术［全喉切除（TL）或部分喉切除（PL）］与非手术治 疗［放化疗（CRT）或同步放化疗（CCRT）］的临床及随访资料，手术组 136 例（TL 100 例，PL 36 例），非手术组 54 例 （CRT 42例，CCRT 12例），分析2组总体及各临床、病理亚组治疗后5年生存结局及生存影响因素。结果 手术组与 非手术组 5 年总生存率（OS）分别为 50.7％和 33.3％（Log-rank χ2=9.116，P＜0.01），5 年无进展生存率（PFS）分别为 46.3%和22.2%（Log-rank χ2=13.927，P＜0.01）。原发瘤声门上型、T4期、淋巴结转移、临床Ⅳ期喉癌手术组5年OS较 高（P＜0.01）。非手术组8例T4b期患者5年内全部死亡；46例化疗有效患者5年OS为39.1%，与手术组（50.7%）比较 差异无统计学意义（Log-rank χ2=1.855，P＞0.05）；11例患者行挽救性TL，5年OS为45.5%，与手术组（50.7%）比较差 异无统计学意义（Log-rank χ2=0.114，P＞0.05）。与手术组相比，非手术组患者死亡的风险相对增高（HR=2.580， 95%CI：1.665～3.997，P＜0.01）。多因素分析显示吸烟、淋巴结转移、临床Ⅳ期、肿瘤复发是影响晚期喉癌OS的独立 危险因素（均P＜0.05）。结论 局部晚期喉癌以手术为基础的综合治疗远期疗效较好；对诱导化疗有效的患者可试 行保留喉功能的非手术治疗，治疗失败者行挽救性全喉切除可能改善患者的远期生存

关键词: 喉肿瘤, 癌, 鳞状细胞, 化放疗, 放化疗, 辅助, 喉切除术, 存活率分析, 预后, 局部晚期喉癌

Abstract: Abstract: Objective To compare the long-term efficacy of surgical and non-surgical comprehensive therapies in the treatment of locally advanced laryngeal cancer (T3-4N0-3M0), and to explore the treatment options for the advanced laryngeal cancer. Methods The clinical data and follow-up data of 190 patients initially diagnosed with locally advanced laryngeal cancer and underwent surgical (total laryngectomy or partial laryngectomy, TL/PL) and non-surgical (chemoradiotherapy or concurrent chemoradiotherapy, CRT/CCRT) treatments in our hospital were enrolled in the study for a retrospective analysis. The 5-year survival results and survival influencing factors in two groups as well as clinical and pathological subgroups were explored and discussed. Results There were 136 patients in the surgical group (TL 100 cases, PL 36 cases) and 54 patients in the non-surgical group (CRT 42 cases and CCRT 12 cases), of which the 5-year overall survival (OS) rates were 50.7% and 33.3% in surgical group and non-surgical group respectively (Log-rank χ2=9.116，P＜0.01). The 5-year progressionfree survival (PFS) rates were 46.3% and 22.2% respectively (Log-rank χ2=13.927，P＜0.01). For patients with T4 tumors, clinical stage Ⅳ, lymph node metastasis and supraglottic laryngeal cancer, the 5-year OS was higher in the surgical group than that in the non-surgical group (P＜0.01). In the non-surgical group, 8 patients with T4b stage died within 5 years. The 5-year OS of 46 patients who effectively responded to the induction chemotherapy was 39.1%, which was not statistically different from that of the surgical group (50.7%, Log-rank χ2=1.855, P＞0.05). Eleven patients underwent salvage TL with a 5-year OS of 45.5%, which was not statistically different from that of the surgical group (Log-rank χ2=0.114, P＞0.05). Moreover, compared with the surgical group, patients of the non-surgical group showed a higher risk of death (HR=2.580, 95%CI: 1.665-3.997, P＜0.01). Multivariate analysis showed that smoking, lymphatic metastasis, clinical stage Ⅳ and tumor recurrence were independent prognostic factors for OS of advanced laryngeal cancer (P＜0.05). Conclusion For locally advanced laryngeal cancer, the long-term efficacy of comprehensive therapy based on surgical treatment is better than that of the non-surgical treatment. Patients who are effective to induction chemotherapy could try non-surgical treatment to preserve laryngeal function. The salvage of total laryngectomy may improve the long-term survival for patients with non-surgical treatment failure.

Key words: laryngeal neoplasms, carcinoma, squamous cell, chemoradiotherapy, adjuvant, laryngectomy, survival
analysis, prognosis, locally advanced laryngeal cancer